Glymphatic MRI in Clinically Isolated Syndrome

Status Not yet recruiting

Clinical Trial Summary

The brain possesses a system to get rid of unwanted substances, named Glymphatic System (GS). When this system is faulty, these accumulate, there is local inflammation, and progressive death of the cells. This occurs in neurological diseases including Parkinson's, or Alzheimer's. Inflammation and progressive death of the cells are also present in another neurological disorder, named Multiple Sclerosis (MS). Doctors think that GS dysfunction plays a role in MS too. In this research therefore, the aim is to study whether it drives inflammation, and disease progression in MS patients. The researchers have developed a new way to find signs of alteration of the GS using a scan named Magnetic Resonance Imaging (MRI) and will use it in a pilot study on patients with a condition named Clinically Isolated Syndrome (CIS), which often represents the very beginning of MS. It would therefore be demonstrated that the GS is a new mechanism of disease in CIS, which may associate with the symptoms, or the alterations in the levels of some substances in the blood suggestive of brain cells damage. Should this study be successful, this would provide preliminary evidence to perform a larger research study to assess if GS dysfunction drives the progression of MS.

Clinical Trial Description

This is a cross-sectional case-control study on patients with a diagnosis of Clinically Isolated Syndrome (CIS) and a group of age- and gender-matched healthy controls. In this study all participants will undergo two visits. In the first visit, all participants will sign the informed consent form and perform a detailed neurological examination, with administration of a few questionnaires for assessment of symptoms related to CIS/Multiple Sclerosis. Participants will also donate a sample of blood for safety analysis, analysis of biomarkers related to CIS and the glymphatic system, as well as for storage in a biobank. Participants will donate a sample of urine for urinalysis and pregnancy test in females of childbearing potential. In the second visit, all participants will visit the Mireille Gillings Neuroimaging Centre of the University of Exeter for an MRI scan, that will last about 60 minutes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06274671
Study type	Observational
Source	University of Exeter
Contact	Edoardo R de Natale, MD
Phone	07503741242
Email	e.de-natale@exeter.ac.uk
Status	Not yet recruiting
Phase
Start date	March 1, 2024
Completion date	May 15, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04798651` - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis	N/A
Recruiting	`NCT03979391` - Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome	N/A
Completed	`NCT02549703` - Mitochondrial Dysfunction and Disease Progression
Recruiting	`NCT03541226` - Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
Active, not recruiting	`NCT04998851` - A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab	Phase 4
Recruiting	`NCT05277740` - Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
Recruiting	`NCT03004079` - Clinical Importance of Glucose Regulation in Relapsing MS
Completed	`NCT02043964` - Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion	N/A
Completed	`NCT00287079` - A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome	Phase 3
Terminated	`NCT04599023` - Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System
Completed	`NCT01728922` - Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome	Phase 1/Phase 2
Completed	`NCT01737372` - A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis	N/A
Terminated	`NCT00595920` - Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis	Phase 2
Recruiting	`NCT05204459` - MS-ResearchBiomarkerS
Completed	`NCT04705610` - Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography	N/A
Recruiting	`NCT03610139` - Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients	N/A
Active, not recruiting	`NCT04009005` - Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis	N/A
Not yet recruiting	`NCT06280755` - Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Completed	`NCT03872583` - Understanding Magnetic Resonance Imaging in Multiple Sclerosis	N/A
Terminated	`NCT00819897` - Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta	N/A